My thanks to the positive and objectively critical responders to my post. I exclude Sorepocket from that group.
I do appreciate that MSB's comments must be such that the market is kept fully informed, while some things must be kept commercial in confidence.
That as why I inserted the comment about legal clearance prior to broadcast. I also acknowledge that, as MESO particularly, is a very small company by USA standards, with many potential breakthrough developments on their radar, the Board must be pretty busy. However, I have found that their PR people do not even acknowledge receipt of emails, let alone respond to them. I note that other posters have complained about this on HC. This may not be the Boards fault, rather the PRs. However, I do feel that many shareholder posters are beginning to feel like edible fungus. Positive things can be said, with prior legal vetting, more frequently in my opinion. I just raise the point for consideration.
Yes, I overlooked the Lasserman letter.That famous Australian , Blind Freddy , can see that a major Pharma is behind that. No doubt RemL would
take a big share of the market away from what is probably their very inferior drug. I feel that MSB's data is strong enough to counter that one at an FDA level. It's not the sort of thing to attack at a forum level.
I am not a bioscientist, but I do have a lifetime of research under my belt. I know a fair amount about experimental research design and how to judge the quality of journals. The editors of those journals know how to pick peer reviewers, so acceptance for publication is validation enough for me. MSB
has published in top journals. The authors have answered the reviewers concerns pre their final article. On that information i have bought, over the past 6 or 7 years, a six-figure number of shares, none of which I have sold. Thus, I am very positive about the potential of the company. I would just like them to make some very small shareholder communication improvements, which is not a lot to ask. It goes without saying that i would like Sorepocket and his ilk, to realise that they are not wanted and have nothing worthwhile to contribute here. Kindly desist.
- Forums
- ASX - By Stock
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
My thanks to the positive and objectively critical responders to...
-
- There are more pages in this discussion • 531 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B |
Open | High | Low | Value | Volume |
$1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24758 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 73626 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10033 | 1.485 |
4 | 53700 | 1.480 |
1 | 770 | 1.475 |
3 | 62048 | 1.460 |
1 | 50000 | 1.455 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 21995 | 1 |
1.505 | 24000 | 1 |
1.510 | 13666 | 2 |
1.515 | 99798 | 1 |
1.520 | 27250 | 3 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |